ARCHIVES

Conferees Set NIH Funding At $30 Billion.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

Guest Editorial: Gerard Silvestri calls for uniform guideline for CT screening for lung cancer

July 1, 2011

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988